Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
Abstract In recent years, magnolol (MG), a natural active compound of polyphenolic nature, has garnered significant interest for its anti-cancer effects. Numerous studies conducted on cell lines and animal models have indicated a positive impact of administering drugs or semi-synthesized products de...
Saved in:
| Main Authors: | Asmita Rayamajhi, Nisha Gyawali, Deepa Karki, Luis E. Pérez-Caltzontzin, Sheila I. Peña-Corona, Hernán Cortés, Achyut Adhikari, Gerardo Leyva-Gómez, Yadav Uprety, Solomon Habtemariam, Lashyn Kiyekbayeva, Javad Sharifi-Rad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02409-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing old natural compounds to target new pathogens: honokiol and magnolol against Candida auris
by: Mihai Mares, et al.
Published: (2024-12-01) -
Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
by: Abdullah Al Emran, et al.
Published: (2019-03-01) -
Inhibition of Bovine Enterovirus Infection by Magnolol via Modulating the Gut Microbiota in Mice
by: Junying Hu, et al.
Published: (2025-05-01) -
Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01) -
Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
by: Xian Lin, et al.
Published: (2025-04-01)